论文部分内容阅读
目的:探讨腺苷负荷心肌灌注显像在冠状动脉介入治疗中的临床价值。方法:116例冠心病疑似患者住院,行腺苷负荷心肌灌注显像和冠状动脉造影,根据需要进行介入治疗,介入治疗后3～7天复查腺苷负荷心肌灌注显像。结果:73例冠心病患者中,66例得到介入处理,其中32例患者冠状动脉介入处理后复查腺苷负荷心肌灌注显像,介入后心肌核素血流灌注较介入前明显改善(P<0.01)。结论:腺苷负荷心肌灌注显像对于冠心病患者冠状动脉介入前病变成程度分析以及介入后疗效判断有一定的临床意义。
Objective: To investigate the clinical value of adenosine stress myocardial perfusion imaging in the treatment of coronary artery disease. Methods: One hundred and sixteen patients with suspected CAD were hospitalized, adenosine stress myocardial perfusion imaging and coronary angiography were performed. According to the need for interventional therapy, adenosine stress myocardial perfusion imaging was performed 3 ~ 7 days after interventional therapy. Results: Thirty-six patients with coronary heart disease were involved in the intervention. Among them, 32 patients underwent adenosine stress myocardial perfusion imaging after coronary intervention, and myocardial perfusion was significantly improved after intervention (P <0.01) ). Conclusion: Adenosine stress myocardial perfusion imaging in patients with coronary heart disease before coronary artery disease into a degree of analysis and to determine the efficacy of intervention has some clinical significance.